Canada’s The Star traces the “chemical imbalance” story’s fall from bedrock scientific principle to marketing device, at the same time that a $70 billion worldwide drug market was built on the theory. “The view among neuroscientists,” says Edward Shorter, a medical historian at the University of Toronto, “is that this emphasis on neurotransmitters as the cause of mental illness is more of a (drug sales) concept than a scientific concept. It helps drug companies sell drugs.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.